photographs UlcerGard Generic Name: omeprazole oral paste Dosage Form: FOR ANIMAL USE ONLY UlcerGard (omeprazole) Oral Paste for Horses PREVENTS STOMACH ULCERS BY REDUCING ACID PRODUCTION Stomach ulcers are more common in horses than once believed. Studies have demonstrated stomach ulcers in over 90% of racehorses and 60% of performance horses in various disciplines. Horses secrete acid in their stomach 24 hours a day. Horses on grass pasture or eating large quantities of roughage infrequently develop stomach ulcers. Horses without continual access to roughage or in rigorous training are at greater risk of stomach ulceration due to the effects of acid on the stomach lining. The additional stresses of traveling, competition, stall confinement, and strenuous exercise can also contribute to the development of stomach ulcers in horses. UlcerGard works to prevent stomach ulcers in horses. The active ingredient in UlcerGard, omeprazole has been extensively tested for safety and effectiveness. It works by reducing the production of acid in the horse's stomach. To help horses maintain optimal gastric health, it is recommended that UlcerGard be administered during stressful events or activities that may induce stomach ulcers. Such conditions may include: training, racing, showing, traveling, stall confinement, and competition. DIRECTIONS FOR USE Each syringe contains 4 individual daily doses for horses weighing 600-1200 lbs. Please refer to the following dosage chart for help in determining the correct dose for your horse. UlcerGard DOSAGE CHART HORSE WEIGHT DOSE * * Duration of 8 or 28 days Less than 600 lbs Consult a veterinarian 600-1200 lbs 1 dose per day over 1200 lbs 2 doses once per day SYRINGE INSTRUCTIONS 1) To set the syringe plunger, unlock the dose ring by rotating turn and slide the dose ring along the plunger shaft so that the side nearest the barrel is set at the appropriate daily dose marking. 2) Rotate turn to lock ring before dosing. 3) Make sure horse's mouth contains no feed before administration. 4) Remove syringe tip cover. 5) Insert syringe into the corner of the horse's mouth. 6) Depress the plunger until it stops at the dose ring. The entire dose should be deposited on the back of the tongue or deep in the cheek pouch. Horses should be observed briefly to assure no part of the dose is lost or rejected. If any of the dose is lost, re-dosing is recommended. Replace cap if any unused doses remain in the syringe. ACTIVE INGREDIENT omeprazole USES For the prevention of gastric ulcers in horses. DOSAGE The minimum recommended dosage is 1 mg/kg per day (0.45 mg/lb) or 1/4 syringe. When given once daily during the stressful period, UlcerGard has been shown to effectively prevent stomach ulcers in horses. This effect was tested in horses exposed to stressful conditions for either 8 or 28 days. Warning Not for use in humans. Keep this and all medications out of the reach of children. In case of ingestion by humans, contact a physician. Do not use in horses intended for human consumption. To obtain product information call 1-877-MERIAL-E. INFORMATION FOR HORSE OWNERS UlcerGard is intended for use in healthy horses. If you notice any signs of illness prior to or during the use of this product, consult your veterinarian for appropriate diagnosis and treatment recommendations. UlcerGard may be used in horses that weigh at least 600 lbs. The effectiveness of UlcerGard in the prevention of gastric ulcers in foals and weanlings has not been evaluated. UlcerGard may be used safely in breeding stallions. Safety in pregnant mares has not been determined. Once daily administration of UlcerGard is recommended in horses exposed to stressful conditions which may include: training, racing, showing, traveling, stall confinement, and competition. UlcerGard is intended for use only in the prevention of gastric ulcers in healthy horses. Clinical signs of gastric ulcers may include: decreased appetite, recurrent colic, intermittent loose stools or diarrhea, poor hair coat, poor body condition or poor performance. These signs may also be associated with other diseases as well as existing gastric ulcers. If your horse is exhibiting one or more of these signs, consult your veterinarian for diagnosis and treatment. STORAGE INFORMATION Store at 68 F-77 F (20-25 C). Excursions between 59 F-86 F (15-30 C) are permitted. CUSTOMER ASSISTANCE AND WEB SITE For more information, please call 1-877-MERIAL-E or visit our web site: www.UlcerGard.com. UlcerGard is a registered trademark of the AstraZeneca Group of Companies. 2010 Merial. All rights reserved. US Patent: 4255431 and 5708017 1900/01 - Rev. 03-2010 Marketed by: Merial LLC, Duluth, GA 30096-4640, U.S.A. Made in Brazil PRINCIPAL DISPLAY PANEL - 6 Syringe Carton UlcerGard (omeprazole) Oral Paste for Horses NADA 141-227, Approved by FDA For the prevention of gastric ulcers in horses Once-a-Day Dosing with a well-accepted paste 6 PACK - 24 Total Doses Contains 6 Syringes (4 Doses Each) MERIAL UlcerGard omeprazole paste Product Information Product Type OTC ANIMAL DRUG Item Code (Source) NDC:50604-9719 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength omeprazole (omeprazole) omeprazole 370 mg in 1 g Product Characteristics Color YELLOW Score Shape Size Flavor CINNAMON Imprint Code Contains Packaging # Item Code Package Description 1 NDC:50604-9719-1 1 SYRINGE, PLASTIC (SYRINGE) in 1 CARTON 1 6.15 g in 1 SYRINGE, PLASTIC 2 NDC:50604-9719-2 6 SYRINGE, PLASTIC (SYRINGE) in 1 CARTON 2 6.15 g in 1 SYRINGE, PLASTIC Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NADA NADA141227 02/18/2004 Labeler - Merial Limited (034393582) Revised: 06/2010 Merial Limited Print this page FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Recently Approved Lonhala Magnair Lonhala Magnair (glycopyrrolate) is a long-acting muscarinic antagonist (LAMA) bronchodilator for... Ozempic Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog administered once-weekly for the... Ogivri Ogivri (trastuzumab-dkst) is a HER2 / neu receptor antagonist biosimilar to Herceptin indicated for... Sublocade Sublocade (buprenorphine) is a once-monthly injectable partial opioid agonist formulation for the... More absolutely everyone
therapies UlcerGard a designated
EmoticonEmoticon